Spots Global Cancer Trial Database for Safety Evaluation of ExAblate MRgFUS for Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety Evaluation of ExAblate MRgFUS for Prostate Cancer
Official Title: Safety, Compatibility and Imaging Quality of ExAblate Prostate Applicator for Prostate Cancer
Study ID: NCT00811265
Conditions
Interventions
Study Description
Brief Summary: Evaluate the safety, compatibility and imaging quality of the ExAblate MRgFUS system.
Detailed Description: The objective of this study is to evaluate safety, compatibility and imaging quality of the ExAblate MRgFUS system for prostate cancer, under simulated use conditions. No acoustic energy will be delivered and no focused ultrasound therapy will be performed. This is an imaging only study.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Sheba Medical Center, Tel Hashomer, , Israel
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
